Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $117000.0.

  • ProPhase Labs' Change in Accured Expenses fell 8733.77% to $117000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $811000.0, marking a year-over-year decrease of 9001.23%. This contributed to the annual value of $5.1 million for FY2024, which is 7700.91% up from last year.
  • Per ProPhase Labs' latest filing, its Change in Accured Expenses stood at $117000.0 for Q3 2025, which was down 8733.77% from $900000.0 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Change in Accured Expenses ranged from a high of $7.8 million in Q1 2021 and a low of -$5.5 million during Q3 2021
  • For the 5-year period, ProPhase Labs' Change in Accured Expenses averaged around $239210.5, with its median value being $681000.0 (2023).
  • Data for ProPhase Labs' Change in Accured Expenses shows a peak YoY increase of 287262.36% (in 2021) and a maximum YoY decrease of 253489.93% (in 2021) over the last 5 years.
  • Over the past 5 years, ProPhase Labs' Change in Accured Expenses (Quarter) stood at -$1.5 million in 2021, then decreased by 18.63% to -$1.8 million in 2022, then skyrocketed by 281.22% to $3.3 million in 2023, then tumbled by 92.55% to $246000.0 in 2024, then plummeted by 52.44% to $117000.0 in 2025.
  • Its last three reported values are $117000.0 in Q3 2025, $900000.0 for Q2 2025, and -$452000.0 during Q1 2025.